These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 354799)

  • 1. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
    Palladino MA; Thorbecke GJ
    Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to carcinogen-induced transplantable fibrosarcomas in B2/B2 chickens. IV. Effect of whole-body gamma radiation on localization and growth of intravenously injected tumor cells.
    Palladino MA; Galton JE; Hochwald GM; Thorbecke GJ
    J Natl Cancer Inst; 1979 Sep; 63(3):737-43. PubMed ID: 112314
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to transplantable carcinogen induced fibrosarcomas in B2/B2 chickens. II. Macrophage dependency of adoptive T cell mediated tumor immunity.
    Palladino MA; Thorbecke GJ
    Cell Immunol; 1978 Jul; 38(2):350-64. PubMed ID: 307987
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
    Edelman AS; Xue B; Sanchez P; Thorbecke GJ
    J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. III. Tumor growth inhibition by local delayed hypersensitivity reactions to unrelated antigens.
    Palladino MA; Thorbecke GJ
    Eur J Immunol; 1978 Apr; 8(4):257-62. PubMed ID: 668800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction in B2/B2 chickens of immunity to transplantable carcinogen-induced fibrosarcomas mediated by T-cell monocyte cooperation: role of delayed hypersensitivity to unrelated antigens.
    Palladino MA; Thorbecke GJ
    Adv Exp Med Biol; 1977; 88():331-43. PubMed ID: 303451
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. II. Effect of prior immunization with transplantable tumors on primary tumor incidence.
    Edelman AS; Xue B; Galton JE; Sanchez P; Thorbecke GJ
    J Immunol; 1985 Sep; 135(3):2213-9. PubMed ID: 3926899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 10. Requirements for induction of delay hypersensitivity in the chicken.
    Palladino MA; Grebenau MD; Thorbecke GJ
    Dev Comp Immunol; 1978 Feb; 2(1):121-32. PubMed ID: 76579
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of antitumor immunity--immunobiologic approaches.
    North RJ; Dye ES; Mills CD; Chandler JP
    Springer Semin Immunopathol; 1982; 5(2):193-220. PubMed ID: 6293113
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
    Moroson H; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity to carcinogen-induced transplantable fibrosarcoma in B2/B2 chickens. V. Relationship to tumor cell-specific delayed hypersensitivity and serum antibody.
    Galton JE; Palladino MA; Xue B; Edelman AS; Thorbecke GJ
    Cell Immunol; 1982 Nov; 73(2):247-63. PubMed ID: 6186403
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the potentiation of specific tumor immunity in mice by Corynebacterium parvum or BCG.
    Scott MT; Bomford R
    J Natl Cancer Inst; 1976 Sep; 57(3):555-9. PubMed ID: 978769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
    Parr IB; Wheeler LE; Alexander P
    Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of bacterial adjuvants on allograft survival after anti-lymphocyte serum (ALS) and donor bone marrow in mice.
    Clark AW; Monaco AP
    Immunology; 1974 Nov; 27(5):887-93. PubMed ID: 4373388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.